We report the first case of glossal necrotizing myositis by group A beta-hemolytic Streptococcus in an 8-year-old girl on chronic nonsteroidal anti-inflammatory drugs, immunomodulators, and steroids ...

AN epidemiologic study of streptococcal infection among 1000 children, attending three Philadelphia public schools, was conducted from October, 1955, through May, 1959. It offered an opportunity for a ...

THE danger of hemolytic streptococcus respiratory infection to persons who are susceptible to rheumatic fever is well recognized. Since with present knowledge there are inherent difficulties in ...

OBJECTIVE: To determine the incidence of early-onset group B beta hemolytic streptococcal (EOGBS) infection and the association between changes in the incidence and intrapartum antibiotic prophylaxis ...

Beta-hemolytic group A streptococcus or Streptococcus pyogenes, a gram-positive human pathogen that habitually colonizes the throat or skin of the host, is a cause of streptococcal pharyngitis – more ...

Group A Streptococcus remains a global health burden with an estimated 700 million cases reported annually, and more than half a million deaths due to severe infections. A new avenue has been found ...

Study results demonstrate that approximately 1 in 3 children treated for PSD will have a return encounter for a clinical recurrence. Among children treated with oral penicillin or amoxicillin, the ...

Strep throat is a bacterial infection caused by Group A beta hemolytic streptococci. It affects most commonly infants and elderly people but adults and older children can also be affected. It is more ...

Quidel Corporation has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market Quidel's new Solana® Strep Complete Assay for the rapid and ...